Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

In a festive spirit, Elon Musk, the 53-year-old CEO of Tesla and SpaceX, shared a humorous image of himself dressed as Santa ...

Elon Musk/X Mounjaro, like Ozempic, is a GLP-1 inhibitor – a class of drugs developed to help people with diabetes regulate their blood glucose and insulin levels. However, Americans have ...

Both Ozempic and Mounjaro are GLP-1 inhibitors meant to help people with diabetes, but they are often used for weight loss. He said the GLP-1 “seems to have fewer side effects and be more ...

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Kennedy Jr. over the widespread use and long-term benefits of GLP-1 inhibitors in battling obesity. Posting to his social media platform X (formerly Twitter), Musk shared an image of himself ...

“There are reports of persons using GLP-1 inhibitors losing their interest in alcohol,” says Anne McTiernan, MD, PhD, an internist and epidemiologist at Fred Hutchinson Cancer Center in ...

Elon Musk revealed that he uses the weight-loss drug Mounjaro and praises it for having fewer side effects than Ozempic.

Mounjaro is a GLP-1 inhibitor developed to help people with diabetes regulate their blood glucose. Elon Musk, the 53-year-old CEO of Tesla and SpaceX, recently shared a festive image of himself ...